TP-5801 (TFA)
TP-5801 TFA is an orally active TNK1 (non-receptor tyrosine kinase) inhibitor (IC50=1.40 nM), and shows anti-tumor activity[1].
Product Specifications
UNSPSC
12352005
Target
STAT; TNK1
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tp-5801-tfa.html
Purity
99.55
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(C(F)(F)F)=O.CN1CCN(C2=C(C)C=C(NC3=NC=C(Br)C(NC4=CC=CN=C4N(C)C)=N3)C(OC)=C2)CC1
Molecular Formula
C26H32BrF3N8O3
Molecular Weight
641.48
References & Citations
[1]Tsz-Yin Chan, et al. TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth. Nat Commun. 2021 Sep 9;12 (1) :5337.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B302761-50MG 50 mg
Bis (2-Hydroxyethyl) 2-hydroxyterephthalate (BHET-OH)-d8
Sign In for Pricing
View Details 
BNC042034-100 1x 100 µL
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (LPFS2/2034R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB3193-100 1x 100 µL
Prohibitin (Mitochondrial Marker) (PHB/3193), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 